

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of heat generation (GO:0031652) | 9.13056753 |
| 2 | cellular response to ATP (GO:0071318) | 8.83535320 |
| 3 | aminoglycoside antibiotic metabolic process (GO:0030647) | 8.00595548 |
| 4 | regulation of synapse structural plasticity (GO:0051823) | 7.56664429 |
| 5 | regulation of vitamin D biosynthetic process (GO:0060556) | 7.21971395 |
| 6 | regulation of heat generation (GO:0031650) | 7.16981662 |
| 7 | maintenance of protein location in nucleus (GO:0051457) | 6.98551670 |
| 8 | somite rostral/caudal axis specification (GO:0032525) | 6.94709941 |
| 9 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 6.43557698 |
| 10 | negative regulation of epidermis development (GO:0045683) | 6.37866416 |
| 11 | regulation of response to osmotic stress (GO:0047484) | 6.31270035 |
| 12 | adenosine receptor signaling pathway (GO:0001973) | 6.30129663 |
| 13 | regulation of fever generation (GO:0031620) | 6.20804987 |
| 14 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 6.14347695 |
| 15 | response to ATP (GO:0033198) | 6.09607194 |
| 16 | tachykinin receptor signaling pathway (GO:0007217) | 5.65749261 |
| 17 | regulation of vitamin metabolic process (GO:0030656) | 5.62825056 |
| 18 | muscle organ morphogenesis (GO:0048644) | 5.59188881 |
| 19 | negative regulation of cell aging (GO:0090344) | 5.53690546 |
| 20 | histone H4-K8 acetylation (GO:0043982) | 5.48572901 |
| 21 | histone H4-K5 acetylation (GO:0043981) | 5.48572901 |
| 22 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.48566577 |
| 23 | DNA strand renaturation (GO:0000733) | 5.46704317 |
| 24 | regulation of cilium movement (GO:0003352) | 5.42469468 |
| 25 | rRNA transcription (GO:0009303) | 5.33478385 |
| 26 | negative regulation of telomerase activity (GO:0051974) | 5.26714025 |
| 27 | response to dietary excess (GO:0002021) | 5.20191276 |
| 28 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.14131598 |
| 29 | protein localization to kinetochore (GO:0034501) | 5.09761920 |
| 30 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 5.04917631 |
| 31 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.03618066 |
| 32 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 5.03121821 |
| 33 | histone H4-K12 acetylation (GO:0043983) | 4.92167494 |
| 34 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.88242350 |
| 35 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.88195635 |
| 36 | hormone catabolic process (GO:0042447) | 4.87548363 |
| 37 | coenzyme catabolic process (GO:0009109) | 4.79103174 |
| 38 | regulation of skeletal muscle contraction (GO:0014819) | 4.76127888 |
| 39 | notochord development (GO:0030903) | 4.75689960 |
| 40 | phenol-containing compound catabolic process (GO:0019336) | 4.74773512 |
| 41 | positive regulation of protein kinase C signaling (GO:0090037) | 4.68271512 |
| 42 | purine ribonucleotide transport (GO:0015868) | 4.53547766 |
| 43 | vitamin A metabolic process (GO:0006776) | 4.51626714 |
| 44 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.51191613 |
| 45 | proline transport (GO:0015824) | 4.51030747 |
| 46 | cytidine deamination (GO:0009972) | 4.50230193 |
| 47 | cytidine metabolic process (GO:0046087) | 4.50230193 |
| 48 | cytidine catabolic process (GO:0006216) | 4.50230193 |
| 49 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.43327190 |
| 50 | regulation of protein kinase A signaling (GO:0010738) | 4.38466196 |
| 51 | primitive streak formation (GO:0090009) | 4.36511334 |
| 52 | cellular modified amino acid catabolic process (GO:0042219) | 4.34794639 |
| 53 | interferon-gamma production (GO:0032609) | 4.34703342 |
| 54 | bone trabecula formation (GO:0060346) | 4.32790890 |
| 55 | nucleotide transmembrane transport (GO:1901679) | 4.32303846 |
| 56 | meiotic chromosome segregation (GO:0045132) | 4.26546780 |
| 57 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.25801021 |
| 58 | mitochondrion distribution (GO:0048311) | 4.21699696 |
| 59 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 4.21632931 |
| 60 | transepithelial transport (GO:0070633) | 4.19163014 |
| 61 | detection of temperature stimulus (GO:0016048) | 4.18288633 |
| 62 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.18105498 |
| 63 | regulation of chemokine biosynthetic process (GO:0045073) | 4.17976094 |
| 64 | positive regulation of digestive system process (GO:0060456) | 4.14050975 |
| 65 | quinone metabolic process (GO:1901661) | 4.13876236 |
| 66 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 4.10055178 |
| 67 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.09803551 |
| 68 | mitotic sister chromatid segregation (GO:0000070) | 4.09332195 |
| 69 | heterochromatin organization (GO:0070828) | 4.08291005 |
| 70 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.06930500 |
| 71 | lens fiber cell differentiation (GO:0070306) | 4.05985785 |
| 72 | nucleoside transmembrane transport (GO:1901642) | 4.03102316 |
| 73 | histone H4-K16 acetylation (GO:0043984) | 4.01216953 |
| 74 | purinergic receptor signaling pathway (GO:0035587) | 4.00840597 |
| 75 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.92850416 |
| 76 | icosanoid secretion (GO:0032309) | 3.88420991 |
| 77 | arachidonic acid secretion (GO:0050482) | 3.88420991 |
| 78 | adenine nucleotide transport (GO:0051503) | 3.87737565 |
| 79 | rRNA methylation (GO:0031167) | 3.86678004 |
| 80 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.86299866 |
| 81 | maintenance of protein localization in organelle (GO:0072595) | 3.84495759 |
| 82 | sensory perception of taste (GO:0050909) | 3.84426671 |
| 83 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.83330984 |
| 84 | positive regulation of macrophage cytokine production (GO:0060907) | 3.82789231 |
| 85 | synaptic vesicle maturation (GO:0016188) | 3.75556956 |
| 86 | phagocytosis, recognition (GO:0006910) | 3.71141104 |
| 87 | positive regulation of amino acid transport (GO:0051957) | 3.62457555 |
| 88 | response to peptidoglycan (GO:0032494) | 3.61359707 |
| 89 | behavioral response to nicotine (GO:0035095) | 3.60682233 |
| 90 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.58766270 |
| 91 | positive regulation of protein deacetylation (GO:0090312) | 3.57165596 |
| 92 | regulation of microtubule-based movement (GO:0060632) | 3.55683390 |
| 93 | nuclear pore complex assembly (GO:0051292) | 3.55031469 |
| 94 | chromatin assembly (GO:0031497) | 3.53772343 |
| 95 | negative regulation of telomere maintenance (GO:0032205) | 3.51216689 |
| 96 | protein polyglutamylation (GO:0018095) | 3.51046430 |
| 97 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.49950806 |
| 98 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.49076247 |
| 99 | microtubule severing (GO:0051013) | 3.46228358 |
| 100 | positive regulation of histone deacetylation (GO:0031065) | 3.46048999 |
| 101 | positive regulation of prostaglandin secretion (GO:0032308) | 3.45394277 |
| 102 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.45065669 |
| 103 | protein carboxylation (GO:0018214) | 3.45065669 |
| 104 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.44891787 |
| 105 | protein localization to chromosome, centromeric region (GO:0071459) | 3.44877040 |
| 106 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.44779202 |
| 107 | retinoic acid receptor signaling pathway (GO:0048384) | 3.42168297 |
| 108 | synaptic transmission, cholinergic (GO:0007271) | 3.41534730 |
| 109 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.41179984 |
| 110 | pre-miRNA processing (GO:0031054) | 3.40925604 |
| 111 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.40231245 |
| 112 | sialylation (GO:0097503) | 3.39040865 |
| 113 | cofactor transport (GO:0051181) | 3.36349498 |
| 114 | regulation of translation in response to stress (GO:0043555) | 3.35395272 |
| 115 | sulfur amino acid catabolic process (GO:0000098) | 3.33523186 |
| 116 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.33259703 |
| 117 | cardiovascular system development (GO:0072358) | 3.32996332 |
| 118 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.32696357 |
| 119 | sister chromatid segregation (GO:0000819) | 3.32239914 |
| 120 | rRNA modification (GO:0000154) | 3.32132138 |
| 121 | positive regulation vascular endothelial growth factor production (GO:0010575) | 3.30837407 |
| 122 | regulation of prostaglandin secretion (GO:0032306) | 3.29024516 |
| 123 | positive regulation of muscle cell apoptotic process (GO:0010661) | 3.28773103 |
| 124 | cellular response to nicotine (GO:0071316) | 3.26744308 |
| 125 | regulation of telomere maintenance (GO:0032204) | 3.26461313 |
| 126 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.26457292 |
| 127 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.26457292 |
| 128 | anterior/posterior axis specification (GO:0009948) | 3.26423385 |
| 129 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.25304868 |
| 130 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.24257166 |
| 131 | purine nucleotide transport (GO:0015865) | 3.21708944 |
| 132 | regulation of vascular endothelial growth factor production (GO:0010574) | 3.21601438 |
| 133 | intestinal epithelial cell development (GO:0060576) | 3.20488710 |
| 134 | phosphatidylinositol 3-kinase signaling (GO:0014065) | 3.20216492 |
| 135 | GDP-mannose metabolic process (GO:0019673) | 3.18475827 |
| 136 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.17832884 |
| 137 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.15223318 |
| 138 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.15162569 |
| 139 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.14219015 |
| 140 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.14006484 |
| 141 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.11984319 |
| 142 | protein insertion into membrane (GO:0051205) | 3.11624298 |
| 143 | ventricular system development (GO:0021591) | 3.11399517 |
| 144 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.10227267 |
| 145 | heme transport (GO:0015886) | 3.06184194 |
| 146 | icosanoid transport (GO:0071715) | 3.04772511 |
| 147 | fatty acid derivative transport (GO:1901571) | 3.04772511 |
| 148 | peristalsis (GO:0030432) | 3.04415313 |
| 149 | negative regulation of interleukin-2 production (GO:0032703) | 3.04338560 |
| 150 | melanin biosynthetic process (GO:0042438) | 3.04102996 |
| 151 | regulation of telomerase activity (GO:0051972) | 3.03343917 |
| 152 | DNA double-strand break processing (GO:0000729) | 3.01521134 |
| 153 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.01439645 |
| 154 | positive regulation of acute inflammatory response (GO:0002675) | 3.00164293 |
| 155 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.98550464 |
| 156 | UV protection (GO:0009650) | 2.97744658 |
| 157 | oligosaccharide catabolic process (GO:0009313) | 2.96764389 |
| 158 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.91423460 |
| 159 | urinary tract smooth muscle contraction (GO:0014848) | 2.90287225 |
| 160 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.89891647 |
| 161 | kynurenine metabolic process (GO:0070189) | 2.88334707 |
| 162 | regulation of chronic inflammatory response (GO:0002676) | 2.85338903 |
| 163 | positive regulation of alcohol biosynthetic process (GO:1902932) | 2.84727923 |
| 164 | positive regulation of organic acid transport (GO:0032892) | 2.84515969 |
| 165 | regulation of glutamate secretion (GO:0014048) | 2.80131690 |
| 166 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.79426633 |
| 167 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.78172101 |
| 168 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.77830488 |
| 169 | melanin metabolic process (GO:0006582) | 2.77317502 |
| 170 | sphingomyelin metabolic process (GO:0006684) | 2.75323618 |
| 171 | neuromuscular synaptic transmission (GO:0007274) | 2.73884770 |
| 172 | ganglioside metabolic process (GO:0001573) | 2.72748324 |
| 173 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.72286217 |
| 174 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.71648304 |
| 175 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.69337541 |
| 176 | detection of light stimulus involved in visual perception (GO:0050908) | 2.69337541 |
| 177 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 2.67580738 |
| 178 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 2.67580738 |
| 179 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 2.67580738 |
| 180 | iron coordination entity transport (GO:1901678) | 2.66340487 |
| 181 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.65390050 |
| 182 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.63533807 |
| 183 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.63533807 |
| 184 | regulation of interferon-alpha production (GO:0032647) | 2.58576673 |
| 185 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.56822803 |
| 186 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.56391000 |
| 187 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.55220753 |
| 188 | regulation of circadian sleep/wake cycle, sleep (GO:0045187) | 2.54348090 |
| 189 | polyketide metabolic process (GO:0030638) | 12.4087071 |
| 190 | doxorubicin metabolic process (GO:0044598) | 12.4087071 |
| 191 | daunorubicin metabolic process (GO:0044597) | 12.4087071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.42361924 |
| 2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 7.20456090 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 7.20456090 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 7.20456090 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 4.40302105 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.88458517 |
| 7 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.34662710 |
| 8 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 3.24039190 |
| 9 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 3.01249614 |
| 10 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.99767552 |
| 11 | P68_20966046_ChIP-Seq_HELA_Human | 2.71162714 |
| 12 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.69778692 |
| 13 | MAF_26560356_Chip-Seq_TH2_Human | 2.69152298 |
| 14 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.60266586 |
| 15 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.60032455 |
| 16 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.49835038 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.48008256 |
| 18 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.42566419 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.39998255 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.37589850 |
| 21 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.30567553 |
| 22 | BCOR_27268052_Chip-Seq_Bcells_Human | 2.29840691 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.28168809 |
| 24 | E2F1_20622854_ChIP-Seq_HELA_Human | 2.21549454 |
| 25 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 2.14039118 |
| 26 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.08743920 |
| 27 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.06261176 |
| 28 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 2.05433612 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.02901180 |
| 30 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 2.01707690 |
| 31 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.00943614 |
| 32 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.00293651 |
| 33 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.00064948 |
| 34 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.93645224 |
| 35 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.91399706 |
| 36 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.91076943 |
| 37 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.89917511 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88418395 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.87039207 |
| 40 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.86408771 |
| 41 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.83355190 |
| 42 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.82840628 |
| 43 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.82680250 |
| 44 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.82024591 |
| 45 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.81598496 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.80644273 |
| 47 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.80616758 |
| 48 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.76851756 |
| 49 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.76138603 |
| 50 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.74449541 |
| 51 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.70940346 |
| 52 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.70851298 |
| 53 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70772337 |
| 54 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70302804 |
| 55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.70160280 |
| 56 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.67613924 |
| 57 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.63009914 |
| 58 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.62206595 |
| 59 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.60652146 |
| 60 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59787549 |
| 61 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.59030942 |
| 62 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.58654376 |
| 63 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.56569838 |
| 64 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.55674113 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55557380 |
| 66 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.55535058 |
| 67 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.54756459 |
| 68 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.54169898 |
| 69 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.52513748 |
| 70 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.48867962 |
| 71 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.46609395 |
| 72 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46419091 |
| 73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45525195 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43140032 |
| 75 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.40902169 |
| 76 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.40504528 |
| 77 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.40462265 |
| 78 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.38986082 |
| 79 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37871862 |
| 80 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37813487 |
| 81 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.37392141 |
| 82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36854121 |
| 83 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.36327972 |
| 84 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.36211239 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35012757 |
| 86 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.32366862 |
| 87 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.30894670 |
| 88 | SA1_27219007_Chip-Seq_Bcells_Human | 1.30407152 |
| 89 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.30286503 |
| 90 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.29504957 |
| 91 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27235135 |
| 92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27194920 |
| 93 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.26481325 |
| 94 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.26145429 |
| 95 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.26092151 |
| 96 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.25114941 |
| 97 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.24315638 |
| 98 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.24052749 |
| 99 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23985939 |
| 100 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23628927 |
| 101 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.23134290 |
| 102 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22618520 |
| 103 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.22563501 |
| 104 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.21261102 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.19997898 |
| 106 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.19887337 |
| 107 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.19185277 |
| 108 | ERA_21632823_ChIP-Seq_H3396_Human | 1.18927369 |
| 109 | EWS_26573619_Chip-Seq_HEK293_Human | 1.18453038 |
| 110 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.18162261 |
| 111 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17662624 |
| 112 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17624238 |
| 113 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.17558283 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16452359 |
| 115 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.16035363 |
| 116 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15567963 |
| 117 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14563351 |
| 118 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.14504446 |
| 119 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.13594275 |
| 120 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13281226 |
| 121 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12391376 |
| 122 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.12251013 |
| 123 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.11639662 |
| 124 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.11542142 |
| 125 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.10035934 |
| 126 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09997163 |
| 127 | P300_27268052_Chip-Seq_Bcells_Human | 1.09024950 |
| 128 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.08627466 |
| 129 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.08402760 |
| 130 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07892087 |
| 131 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.06789164 |
| 132 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05961080 |
| 133 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05957047 |
| 134 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.05553167 |
| 135 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.05180009 |
| 136 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04724911 |
| 137 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.04513745 |
| 138 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.04443615 |
| 139 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04162377 |
| 140 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03723525 |
| 141 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.03606310 |
| 142 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02089311 |
| 143 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 1.00884568 |
| 144 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.00510707 |
| 145 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.00409688 |
| 146 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99663691 |
| 147 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.92669654 |
| 148 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.90993300 |
| 149 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.90276769 |
| 150 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.90276769 |
| 151 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.89735010 |
| 152 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.87450766 |
| 153 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86949203 |
| 154 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83700086 |
| 155 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.82490074 |
| 156 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.81856578 |
| 157 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.81502182 |
| 158 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81090332 |
| 159 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77608752 |
| 160 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.77303243 |
| 161 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77250981 |
| 162 | MYC_22102868_ChIP-Seq_BL_Human | 0.77184262 |
| 163 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.77026202 |
| 164 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.76520244 |
| 165 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.74749770 |
| 166 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.74438856 |
| 167 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.72707146 |
| 168 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.71420783 |
| 169 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.71072990 |
| 170 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.70449296 |
| 171 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.70250294 |
| 172 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.70003940 |
| 173 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.69749681 |
| 174 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69727211 |
| 175 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.69619815 |
| 176 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.68516003 |
| 177 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.68009310 |
| 178 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.67159534 |
| 179 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.66646711 |
| 180 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.66451991 |
| 181 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.65690855 |
| 182 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.64762812 |
| 183 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.64511144 |
| 184 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.63691846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 5.89612799 |
| 2 | MP0005171_absent_coat_pigmentation | 5.55106763 |
| 3 | MP0001986_abnormal_taste_sensitivity | 5.41259032 |
| 4 | MP0002254_reproductive_system_inflammat | 5.25594555 |
| 5 | MP0003303_peritoneal_inflammation | 4.85454519 |
| 6 | MP0005174_abnormal_tail_pigmentation | 4.80070763 |
| 7 | MP0003136_yellow_coat_color | 4.68800762 |
| 8 | MP0004858_abnormal_nervous_system | 4.50871506 |
| 9 | MP0005423_abnormal_somatic_nervous | 4.42226491 |
| 10 | MP0006292_abnormal_olfactory_placode | 4.10269487 |
| 11 | MP0004264_abnormal_extraembryonic_tissu | 4.04159883 |
| 12 | MP0005499_abnormal_olfactory_system | 3.54572335 |
| 13 | MP0005394_taste/olfaction_phenotype | 3.54572335 |
| 14 | MP0005075_abnormal_melanosome_morpholog | 3.49220919 |
| 15 | MP0003122_maternal_imprinting | 3.40841184 |
| 16 | MP0001968_abnormal_touch/_nociception | 3.36201746 |
| 17 | MP0003890_abnormal_embryonic-extraembry | 3.19923040 |
| 18 | MP0003195_calcinosis | 2.92500383 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.89815771 |
| 20 | MP0002736_abnormal_nociception_after | 2.88434692 |
| 21 | MP0002332_abnormal_exercise_endurance | 2.85225213 |
| 22 | MP0010386_abnormal_urinary_bladder | 2.84508235 |
| 23 | MP0001188_hyperpigmentation | 2.72130068 |
| 24 | MP0005257_abnormal_intraocular_pressure | 2.68782745 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 2.56686510 |
| 26 | MP0003121_genomic_imprinting | 2.40757821 |
| 27 | MP0005409_darkened_coat_color | 2.34011913 |
| 28 | MP0006035_abnormal_mitochondrial_morpho | 2.19116162 |
| 29 | MP0009278_abnormal_bone_marrow | 2.14456656 |
| 30 | MP0003183_abnormal_peptide_metabolism | 2.14155712 |
| 31 | MP0005167_abnormal_blood-brain_barrier | 2.10997200 |
| 32 | MP0001502_abnormal_circadian_rhythm | 2.07548668 |
| 33 | MP0000015_abnormal_ear_pigmentation | 2.04907724 |
| 34 | MP0005645_abnormal_hypothalamus_physiol | 2.00165022 |
| 35 | MP0003938_abnormal_ear_development | 1.98776894 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.98504897 |
| 37 | MP0001756_abnormal_urination | 1.97904863 |
| 38 | MP0002653_abnormal_ependyma_morphology | 1.89573100 |
| 39 | MP0009764_decreased_sensitivity_to | 1.84902237 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.83862187 |
| 41 | MP0008057_abnormal_DNA_replication | 1.83819588 |
| 42 | MP0002735_abnormal_chemical_nociception | 1.80912442 |
| 43 | MP0005083_abnormal_biliary_tract | 1.80160149 |
| 44 | MP0008961_abnormal_basal_metabolism | 1.79173991 |
| 45 | MP0006082_CNS_inflammation | 1.74428508 |
| 46 | MP0005535_abnormal_body_temperature | 1.73225050 |
| 47 | MP0000678_abnormal_parathyroid_gland | 1.70585830 |
| 48 | MP0004043_abnormal_pH_regulation | 1.66757417 |
| 49 | MP0002127_abnormal_cardiovascular_syste | 1.63599690 |
| 50 | MP0003453_abnormal_keratinocyte_physiol | 1.59709579 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 1.57210937 |
| 52 | MP0003787_abnormal_imprinting | 1.55897411 |
| 53 | MP0003123_paternal_imprinting | 1.52010088 |
| 54 | MP0010352_gastrointestinal_tract_polyps | 1.50986117 |
| 55 | MP0004957_abnormal_blastocyst_morpholog | 1.49471939 |
| 56 | MP0002233_abnormal_nose_morphology | 1.48889349 |
| 57 | MP0002932_abnormal_joint_morphology | 1.47702053 |
| 58 | MP0001849_ear_inflammation | 1.47551815 |
| 59 | MP0000751_myopathy | 1.46555585 |
| 60 | MP0005365_abnormal_bile_salt | 1.44153762 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.43320729 |
| 62 | MP0009785_altered_susceptibility_to | 1.39105153 |
| 63 | MP0002139_abnormal_hepatobiliary_system | 1.39051343 |
| 64 | MP0000762_abnormal_tongue_morphology | 1.39006604 |
| 65 | MP0003283_abnormal_digestive_organ | 1.37855313 |
| 66 | MP0001672_abnormal_embryogenesis/_devel | 1.36328254 |
| 67 | MP0005380_embryogenesis_phenotype | 1.36328254 |
| 68 | MP0008004_abnormal_stomach_pH | 1.34453048 |
| 69 | MP0001348_abnormal_lacrimal_gland | 1.34075202 |
| 70 | MP0002088_abnormal_embryonic_growth/wei | 1.33534609 |
| 71 | MP0003984_embryonic_growth_retardation | 1.30486104 |
| 72 | MP0010030_abnormal_orbit_morphology | 1.28061446 |
| 73 | MP0003448_altered_tumor_morphology | 1.27882521 |
| 74 | MP0000049_abnormal_middle_ear | 1.27846666 |
| 75 | MP0001293_anophthalmia | 1.27815971 |
| 76 | MP0002092_abnormal_eye_morphology | 1.27430415 |
| 77 | MP0003137_abnormal_impulse_conducting | 1.25281569 |
| 78 | MP0004270_analgesia | 1.24434386 |
| 79 | MP0000569_abnormal_digit_pigmentation | 1.23365980 |
| 80 | MP0008789_abnormal_olfactory_epithelium | 1.23278043 |
| 81 | MP0002114_abnormal_axial_skeleton | 1.16994810 |
| 82 | MP0005248_abnormal_Harderian_gland | 1.15594850 |
| 83 | MP0005332_abnormal_amino_acid | 1.15497491 |
| 84 | MP0000428_abnormal_craniofacial_morphol | 1.14657052 |
| 85 | MP0004381_abnormal_hair_follicle | 1.06967182 |
| 86 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05719983 |
| 87 | MP0002249_abnormal_larynx_morphology | 1.04993263 |
| 88 | MP0001835_abnormal_antigen_presentation | 1.04745394 |
| 89 | MP0005266_abnormal_metabolism | 1.02246126 |
| 90 | MP0003119_abnormal_digestive_system | 1.02019570 |
| 91 | MP0001970_abnormal_pain_threshold | 1.00631831 |
| 92 | MP0000538_abnormal_urinary_bladder | 0.98624106 |
| 93 | MP0002006_tumorigenesis | 0.97908062 |
| 94 | MP0008770_decreased_survivor_rate | 0.97295647 |
| 95 | MP0002970_abnormal_white_adipose | 0.97293745 |
| 96 | MP0004947_skin_inflammation | 0.97143774 |
| 97 | MP0004133_heterotaxia | 0.95385665 |
| 98 | MP0005058_abnormal_lysosome_morphology | 0.94987087 |
| 99 | MP0000749_muscle_degeneration | 0.94112638 |
| 100 | MP0002086_abnormal_extraembryonic_tissu | 0.93132336 |
| 101 | MP0003436_decreased_susceptibility_to | 0.92678151 |
| 102 | MP0000432_abnormal_head_morphology | 0.89917972 |
| 103 | MP0005508_abnormal_skeleton_morphology | 0.89610798 |
| 104 | MP0003755_abnormal_palate_morphology | 0.89323849 |
| 105 | MP0003315_abnormal_perineum_morphology | 0.88367437 |
| 106 | MP0001270_distended_abdomen | 0.88136684 |
| 107 | MP0000350_abnormal_cell_proliferation | 0.87750114 |
| 108 | MP0002419_abnormal_innate_immunity | 0.87279702 |
| 109 | MP0003935_abnormal_craniofacial_develop | 0.86965290 |
| 110 | MP0002751_abnormal_autonomic_nervous | 0.86231000 |
| 111 | MP0005000_abnormal_immune_tolerance | 0.84463705 |
| 112 | MP0004019_abnormal_vitamin_homeostasis | 0.82973958 |
| 113 | MP0005391_vision/eye_phenotype | 0.82441356 |
| 114 | MP0005166_decreased_susceptibility_to | 0.81210725 |
| 115 | MP0000750_abnormal_muscle_regeneration | 0.80737555 |
| 116 | MP0005197_abnormal_uvea_morphology | 0.79568716 |
| 117 | MP0004484_altered_response_of | 0.79276039 |
| 118 | MP0002269_muscular_atrophy | 0.77963941 |
| 119 | MP0001765_abnormal_ion_homeostasis | 0.76785343 |
| 120 | MP0004130_abnormal_muscle_cell | 0.76638058 |
| 121 | MP0002116_abnormal_craniofacial_bone | 0.76286392 |
| 122 | MP0002085_abnormal_embryonic_tissue | 0.74580684 |
| 123 | MP0002132_abnormal_respiratory_system | 0.73727481 |
| 124 | MP0005085_abnormal_gallbladder_physiolo | 0.73189201 |
| 125 | MP0003724_increased_susceptibility_to | 0.72999022 |
| 126 | MP0005410_abnormal_fertilization | 0.72574366 |
| 127 | MP0005025_abnormal_response_to | 0.72409857 |
| 128 | MP0004272_abnormal_basement_membrane | 0.71966048 |
| 129 | MP0001545_abnormal_hematopoietic_system | 0.71936380 |
| 130 | MP0005397_hematopoietic_system_phenotyp | 0.71936380 |
| 131 | MP0008874_decreased_physiological_sensi | 0.71603421 |
| 132 | MP0002396_abnormal_hematopoietic_system | 0.70738147 |
| 133 | MP0002925_abnormal_cardiovascular_devel | 0.70271987 |
| 134 | MP0002084_abnormal_developmental_patter | 0.69759088 |
| 135 | MP0008469_abnormal_protein_level | 0.68790422 |
| 136 | MP0000858_altered_metastatic_potential | 0.68353056 |
| 137 | MP0009046_muscle_twitch | 0.67991123 |
| 138 | MP0004510_myositis | 0.67855916 |
| 139 | MP0002572_abnormal_emotion/affect_behav | 0.67608757 |
| 140 | MP0009840_abnormal_foam_cell | 0.66895933 |
| 141 | MP0002752_abnormal_somatic_nervous | 0.65748632 |
| 142 | MP0000371_diluted_coat_color | 0.65387913 |
| 143 | MP0001486_abnormal_startle_reflex | 0.65070698 |
| 144 | MP0009250_abnormal_appendicular_skeleto | 0.64799640 |
| 145 | MP0004197_abnormal_fetal_growth/weight/ | 0.64381050 |
| 146 | MP0002063_abnormal_learning/memory/cond | 0.63906021 |
| 147 | MP0000163_abnormal_cartilage_morphology | 0.63903232 |
| 148 | MP0000013_abnormal_adipose_tissue | 0.63846053 |
| 149 | MP0003075_altered_response_to | 0.63671072 |
| 150 | MP0003172_abnormal_lysosome_physiology | 0.62971803 |
| 151 | MP0010155_abnormal_intestine_physiology | 0.62010200 |
| 152 | MP0003868_abnormal_feces_composition | 0.61915708 |
| 153 | MP0001542_abnormal_bone_strength | 0.61900456 |
| 154 | MP0004883_abnormal_blood_vessel | 0.61621367 |
| 155 | MP0002909_abnormal_adrenal_gland | 0.61232694 |
| 156 | MP0001243_abnormal_dermal_layer | 0.61149390 |
| 157 | MP0002723_abnormal_immune_serum | 0.60860235 |
| 158 | MP0003942_abnormal_urinary_system | 0.60117180 |
| 159 | MP0002452_abnormal_antigen_presenting | 0.60091777 |
| 160 | MP0001845_abnormal_inflammatory_respons | 0.59888842 |
| 161 | MP0002081_perinatal_lethality | 0.59677193 |
| 162 | MP0000343_altered_response_to | 0.59332486 |
| 163 | MP0010368_abnormal_lymphatic_system | 0.59177160 |
| 164 | MP0000955_abnormal_spinal_cord | 0.58804730 |
| 165 | MP0001663_abnormal_digestive_system | 0.57457460 |
| 166 | MP0002998_abnormal_bone_remodeling | 0.57121015 |
| 167 | MP0009643_abnormal_urine_homeostasis | 0.56991042 |
| 168 | MP0004085_abnormal_heartbeat | 0.56941259 |
| 169 | MP0005551_abnormal_eye_electrophysiolog | 0.55910398 |
| 170 | MP0002108_abnormal_muscle_morphology | 0.55652650 |
| 171 | MP0003091_abnormal_cell_migration | 0.55410390 |
| 172 | MP0003806_abnormal_nucleotide_metabolis | 0.54865476 |
| 173 | MP0005623_abnormal_meninges_morphology | 0.53739967 |
| 174 | MP0009703_decreased_birth_body | 0.53619510 |
| 175 | MP0001191_abnormal_skin_condition | 0.53331012 |
| 176 | MP0005023_abnormal_wound_healing | 0.53167649 |
| 177 | MP0005084_abnormal_gallbladder_morpholo | 0.52637674 |
| 178 | MP0002733_abnormal_thermal_nociception | 0.52207201 |
| 179 | MP0002405_respiratory_system_inflammati | 0.52056021 |
| 180 | MP0005253_abnormal_eye_physiology | 0.51749967 |
| 181 | MP0001664_abnormal_digestion | 0.51662142 |
| 182 | MP0000759_abnormal_skeletal_muscle | 0.51642364 |
| 183 | MP0003861_abnormal_nervous_system | 0.51526953 |
| 184 | MP0000470_abnormal_stomach_morphology | 0.50474405 |
| 185 | MP0005310_abnormal_salivary_gland | 0.50259378 |
| 186 | MP0003221_abnormal_cardiomyocyte_apopto | 0.50237490 |
| 187 | MP0001764_abnormal_homeostasis | 0.47766593 |
| 188 | MP0002136_abnormal_kidney_physiology | 0.46375020 |
| 189 | MP0004924_abnormal_behavior | 0.46267896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 7.73874579 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 6.98259113 |
| 3 | Hepatoblastoma (HP:0002884) | 6.49728794 |
| 4 | Abnormality of the lower motor neuron (HP:0002366) | 5.28536763 |
| 5 | Multiple enchondromatosis (HP:0005701) | 5.15830086 |
| 6 | Attenuation of retinal blood vessels (HP:0007843) | 4.68084526 |
| 7 | Unilateral renal agenesis (HP:0000122) | 4.67255603 |
| 8 | Thin bony cortex (HP:0002753) | 4.53341066 |
| 9 | Rib fusion (HP:0000902) | 4.50567136 |
| 10 | Septo-optic dysplasia (HP:0100842) | 4.21398111 |
| 11 | Poikiloderma (HP:0001029) | 4.05411599 |
| 12 | Congenital stationary night blindness (HP:0007642) | 4.03977320 |
| 13 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.03960212 |
| 14 | Ependymoma (HP:0002888) | 4.00959350 |
| 15 | Facial diplegia (HP:0001349) | 3.99760251 |
| 16 | Testicular atrophy (HP:0000029) | 3.94939917 |
| 17 | Popliteal pterygium (HP:0009756) | 3.86435631 |
| 18 | Hypophosphatemic rickets (HP:0004912) | 3.73261036 |
| 19 | Delayed epiphyseal ossification (HP:0002663) | 3.71673338 |
| 20 | Facial hemangioma (HP:0000329) | 3.71376274 |
| 21 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.71368889 |
| 22 | Ulnar bowing (HP:0003031) | 3.68543934 |
| 23 | Annular pancreas (HP:0001734) | 3.67624237 |
| 24 | Chorioretinal atrophy (HP:0000533) | 3.66645256 |
| 25 | Enlarged epiphyses (HP:0010580) | 3.62699565 |
| 26 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.62079045 |
| 27 | Prolonged partial thromboplastin time (HP:0003645) | 3.60517080 |
| 28 | Turricephaly (HP:0000262) | 3.57727776 |
| 29 | Neoplasm of striated muscle (HP:0009728) | 3.56727940 |
| 30 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.56616384 |
| 31 | Hypoplasia of the fovea (HP:0007750) | 3.56616384 |
| 32 | Choanal stenosis (HP:0000452) | 3.53725383 |
| 33 | Embryonal renal neoplasm (HP:0011794) | 3.52388094 |
| 34 | Akinesia (HP:0002304) | 3.42108566 |
| 35 | Ragged-red muscle fibers (HP:0003200) | 3.30978227 |
| 36 | Anomalous pulmonary venous return (HP:0010772) | 3.27088347 |
| 37 | Abnormality of the salivary glands (HP:0010286) | 3.25604903 |
| 38 | Rhabdomyosarcoma (HP:0002859) | 3.23017029 |
| 39 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.22295339 |
| 40 | Birth length less than 3rd percentile (HP:0003561) | 3.21083215 |
| 41 | Hyperventilation (HP:0002883) | 3.19895824 |
| 42 | Sensory axonal neuropathy (HP:0003390) | 3.18176229 |
| 43 | Fused cervical vertebrae (HP:0002949) | 3.13475684 |
| 44 | Coronal craniosynostosis (HP:0004440) | 3.09239835 |
| 45 | Abnormality of the astrocytes (HP:0100707) | 3.06567032 |
| 46 | Astrocytoma (HP:0009592) | 3.06567032 |
| 47 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.03273580 |
| 48 | Short chin (HP:0000331) | 2.99732658 |
| 49 | Squamous cell carcinoma (HP:0002860) | 2.95529335 |
| 50 | Rectal fistula (HP:0100590) | 2.92967983 |
| 51 | Rectovaginal fistula (HP:0000143) | 2.92967983 |
| 52 | Amyotrophic lateral sclerosis (HP:0007354) | 2.92903177 |
| 53 | Joint hemorrhage (HP:0005261) | 2.90322870 |
| 54 | Aplasia of the musculature (HP:0100854) | 2.89789580 |
| 55 | Anteriorly placed anus (HP:0001545) | 2.89388762 |
| 56 | Bifid tongue (HP:0010297) | 2.88045097 |
| 57 | Partial duplication of thumb phalanx (HP:0009944) | 2.87870701 |
| 58 | Fetal akinesia sequence (HP:0001989) | 2.87244565 |
| 59 | Patellar aplasia (HP:0006443) | 2.83209524 |
| 60 | Generalized hypotonia (HP:0001290) | 2.79322165 |
| 61 | Abnormality of the pulmonary veins (HP:0011718) | 2.78212440 |
| 62 | Abnormal cartilage morphology (HP:0002763) | 2.76650014 |
| 63 | Capillary hemangiomas (HP:0005306) | 2.76598653 |
| 64 | Increased connective tissue (HP:0009025) | 2.74132693 |
| 65 | Abnormality of the fovea (HP:0000493) | 2.73263298 |
| 66 | Tetraplegia (HP:0002445) | 2.72998246 |
| 67 | Narrow nasal bridge (HP:0000446) | 2.68105575 |
| 68 | Mesangial abnormality (HP:0001966) | 2.67687047 |
| 69 | Amblyopia (HP:0000646) | 2.67136689 |
| 70 | Intestinal fistula (HP:0100819) | 2.65162859 |
| 71 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.63258533 |
| 72 | Neonatal respiratory distress (HP:0002643) | 2.61944112 |
| 73 | Periauricular skin pits (HP:0100277) | 2.58554585 |
| 74 | Preauricular pit (HP:0004467) | 2.58554585 |
| 75 | Preauricular skin tag (HP:0000384) | 2.58251999 |
| 76 | Absent septum pellucidum (HP:0001331) | 2.58014899 |
| 77 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.56251066 |
| 78 | Abnormality of the costochondral junction (HP:0000919) | 2.55730942 |
| 79 | Hypochromic anemia (HP:0001931) | 2.55184178 |
| 80 | Amniotic constriction ring (HP:0009775) | 2.54305332 |
| 81 | Abnormality of placental membranes (HP:0011409) | 2.54305332 |
| 82 | Trismus (HP:0000211) | 2.52724374 |
| 83 | Vaginal fistula (HP:0004320) | 2.50982307 |
| 84 | Difficulty running (HP:0009046) | 2.50242171 |
| 85 | Short humerus (HP:0005792) | 2.48897296 |
| 86 | Partial duplication of the phalanx of hand (HP:0009999) | 2.48160592 |
| 87 | Atrioventricular block (HP:0001678) | 2.47575315 |
| 88 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.47220899 |
| 89 | Neoplasm of the heart (HP:0100544) | 2.46709614 |
| 90 | Widely patent fontanelles and sutures (HP:0004492) | 2.46409901 |
| 91 | Neonatal onset (HP:0003623) | 2.45859813 |
| 92 | Tongue fasciculations (HP:0001308) | 2.44927208 |
| 93 | Renal Fanconi syndrome (HP:0001994) | 2.44740968 |
| 94 | Flat occiput (HP:0005469) | 2.44618918 |
| 95 | Nasolacrimal duct obstruction (HP:0000579) | 2.43852690 |
| 96 | Rickets (HP:0002748) | 2.43262299 |
| 97 | Shawl scrotum (HP:0000049) | 2.41632087 |
| 98 | Large earlobe (HP:0009748) | 2.40307683 |
| 99 | Hemorrhage of the eye (HP:0011885) | 2.39229026 |
| 100 | Abnormality of chromosome segregation (HP:0002916) | 2.39058544 |
| 101 | Reduced antithrombin III activity (HP:0001976) | 2.36873914 |
| 102 | Increased number of teeth (HP:0011069) | 2.34563665 |
| 103 | Abnormality of the hepatic vasculature (HP:0006707) | 2.33982443 |
| 104 | Short 5th finger (HP:0009237) | 2.33388656 |
| 105 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.33224514 |
| 106 | Hypoalbuminemia (HP:0003073) | 2.33011055 |
| 107 | Abnormal albumin level (HP:0012116) | 2.33011055 |
| 108 | Renal duplication (HP:0000075) | 2.30982986 |
| 109 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.30576764 |
| 110 | Skin tags (HP:0010609) | 2.28238655 |
| 111 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.26724450 |
| 112 | Muscle fibrillation (HP:0010546) | 2.25965725 |
| 113 | Abnormality of the common coagulation pathway (HP:0010990) | 2.24250466 |
| 114 | Upper limb muscle weakness (HP:0003484) | 2.24110841 |
| 115 | Progressive muscle weakness (HP:0003323) | 2.23837778 |
| 116 | Supernumerary nipples (HP:0002558) | 2.23739013 |
| 117 | Abnormal lung lobation (HP:0002101) | 2.22978736 |
| 118 | Choroideremia (HP:0001139) | 2.21633796 |
| 119 | Dyschromatopsia (HP:0007641) | 2.21565756 |
| 120 | Resting tremor (HP:0002322) | 2.21414241 |
| 121 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.20235236 |
| 122 | Abnormal drinking behavior (HP:0030082) | 2.19629785 |
| 123 | Polydipsia (HP:0001959) | 2.19629785 |
| 124 | Glioma (HP:0009733) | 2.16470626 |
| 125 | Villous atrophy (HP:0011473) | 2.16318603 |
| 126 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.16318603 |
| 127 | Progressive external ophthalmoplegia (HP:0000590) | 2.15974470 |
| 128 | Malignant neoplasm of the central nervous system (HP:0100836) | 2.15723071 |
| 129 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 2.15700883 |
| 130 | Maternal diabetes (HP:0009800) | 2.14541163 |
| 131 | * Horizontal nystagmus (HP:0000666) | 2.12978277 |
| 132 | Ketoacidosis (HP:0001993) | 2.12785002 |
| 133 | Skin nodule (HP:0200036) | 2.12640066 |
| 134 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.12478131 |
| 135 | Absent thumb (HP:0009777) | 2.12379330 |
| 136 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.11502863 |
| 137 | Zonular cataract (HP:0010920) | 2.10594248 |
| 138 | Abnormality of the pubic bones (HP:0003172) | 2.06987941 |
| 139 | Male infertility (HP:0003251) | 2.06820146 |
| 140 | Malnutrition (HP:0004395) | 2.06449454 |
| 141 | Upper motor neuron abnormality (HP:0002127) | 2.06132792 |
| 142 | Hemiparesis (HP:0001269) | 2.04647247 |
| 143 | Premature graying of hair (HP:0002216) | 2.04322131 |
| 144 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.03160395 |
| 145 | Generalized aminoaciduria (HP:0002909) | 2.02766660 |
| 146 | Joint stiffness (HP:0001387) | 2.02532304 |
| 147 | Pseudobulbar signs (HP:0002200) | 2.01696498 |
| 148 | Supernumerary spleens (HP:0009799) | 2.01093260 |
| 149 | Ankle clonus (HP:0011448) | 1.99929479 |
| 150 | Hypopigmentation of the fundus (HP:0007894) | 1.98765110 |
| 151 | Papilledema (HP:0001085) | 1.98429406 |
| 152 | Metaphyseal irregularity (HP:0003025) | 1.97411714 |
| 153 | Supernumerary ribs (HP:0005815) | 1.97291874 |
| 154 | Impulsivity (HP:0100710) | 1.97133615 |
| 155 | Abnormal urine phosphate concentration (HP:0012599) | 1.97117137 |
| 156 | Skin pits (HP:0100276) | 1.96892358 |
| 157 | Glossoptosis (HP:0000162) | 1.96665784 |
| 158 | Abnormal epiphyseal ossification (HP:0010656) | 1.96229323 |
| 159 | Microvesicular hepatic steatosis (HP:0001414) | 1.95475869 |
| 160 | 3-Methylglutaconic aciduria (HP:0003535) | 1.95166262 |
| 161 | Abnormality of the intrinsic pathway (HP:0010989) | 1.93397576 |
| 162 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.93334123 |
| 163 | Abnormality of the musculature of the hand (HP:0001421) | 1.91503007 |
| 164 | Abnormal biliary tract physiology (HP:0012439) | 1.91409100 |
| 165 | Bile duct proliferation (HP:0001408) | 1.91409100 |
| 166 | Lipid accumulation in hepatocytes (HP:0006561) | 1.90841129 |
| 167 | Poor head control (HP:0002421) | 1.89424654 |
| 168 | Achilles tendon contracture (HP:0001771) | 1.88593018 |
| 169 | Hypobetalipoproteinemia (HP:0003563) | 1.88156213 |
| 170 | Nasal polyposis (HP:0100582) | 1.87256392 |
| 171 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.87253177 |
| 172 | Embryonal neoplasm (HP:0002898) | 1.86555866 |
| 173 | Webbed neck (HP:0000465) | 1.86285624 |
| 174 | Dyskinesia (HP:0100660) | 1.86017555 |
| 175 | Myotonia (HP:0002486) | 1.85997678 |
| 176 | Abnormality of the septum pellucidum (HP:0007375) | 1.83840482 |
| 177 | Decreased central vision (HP:0007663) | 1.82787036 |
| 178 | Optic nerve hypoplasia (HP:0000609) | 1.81475160 |
| 179 | Polyuria (HP:0000103) | 1.79826184 |
| 180 | Increased hepatocellular lipid droplets (HP:0006565) | 1.78105630 |
| 181 | Stomatitis (HP:0010280) | 1.77898034 |
| 182 | Elevated alkaline phosphatase (HP:0003155) | 1.77101743 |
| 183 | Malignant hyperthermia (HP:0002047) | 1.76107627 |
| 184 | Breast aplasia (HP:0100783) | 1.73174087 |
| 185 | Cystic hygroma (HP:0000476) | 1.70646780 |
| 186 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.70321609 |
| 187 | Methylmalonic aciduria (HP:0012120) | 1.69990586 |
| 188 | Abnormal glycosylation (HP:0012345) | 1.68027697 |
| 189 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.68027697 |
| 190 | Abnormal protein glycosylation (HP:0012346) | 1.68027697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.69075772 |
| 2 | MAPK15 | 5.79045573 |
| 3 | GRK5 | 5.67673737 |
| 4 | IRAK3 | 5.55348729 |
| 5 | ERN1 | 4.76113601 |
| 6 | GRK6 | 4.26819467 |
| 7 | MUSK | 3.55427572 |
| 8 | WNK4 | 3.33697337 |
| 9 | ADRBK2 | 3.24600197 |
| 10 | BLK | 3.17967626 |
| 11 | GRK1 | 3.08066963 |
| 12 | MATK | 2.96767975 |
| 13 | TYRO3 | 2.95551633 |
| 14 | BMPR2 | 2.88470591 |
| 15 | TGFBR2 | 2.85250971 |
| 16 | NTRK1 | 2.70668326 |
| 17 | CSF1R | 2.67047412 |
| 18 | GRK7 | 2.56594842 |
| 19 | MAPK7 | 2.51977568 |
| 20 | MAP2K4 | 2.18592518 |
| 21 | MOS | 2.06393334 |
| 22 | WNK1 | 2.03993203 |
| 23 | PKN2 | 1.99032840 |
| 24 | TTK | 1.97535487 |
| 25 | IKBKE | 1.80080537 |
| 26 | FRK | 1.79721688 |
| 27 | TBK1 | 1.73264942 |
| 28 | STK10 | 1.72339215 |
| 29 | IKBKB | 1.68349978 |
| 30 | IRAK2 | 1.62285189 |
| 31 | ACVR1B | 1.59262486 |
| 32 | TLK1 | 1.57525162 |
| 33 | MAP3K14 | 1.56697195 |
| 34 | CAMK4 | 1.53595260 |
| 35 | MARK2 | 1.46578547 |
| 36 | ERBB3 | 1.45425316 |
| 37 | CHUK | 1.42023469 |
| 38 | TAOK1 | 1.34836426 |
| 39 | ADRBK1 | 1.27771962 |
| 40 | TESK2 | 1.23186280 |
| 41 | STK38L | 1.22975325 |
| 42 | PRKG2 | 1.22818163 |
| 43 | CSNK1A1L | 1.14169499 |
| 44 | FGFR3 | 1.08184315 |
| 45 | CDK7 | 1.08094734 |
| 46 | DYRK3 | 1.05282372 |
| 47 | ZAP70 | 1.03856585 |
| 48 | HIPK2 | 1.03829896 |
| 49 | EPHA2 | 1.02210008 |
| 50 | MARK3 | 1.01140928 |
| 51 | ZAK | 0.99770888 |
| 52 | MAP3K12 | 0.99187156 |
| 53 | CLK1 | 0.98457813 |
| 54 | AKT3 | 0.96965213 |
| 55 | MAP3K11 | 0.96522644 |
| 56 | CSNK1G3 | 0.95956980 |
| 57 | MAP2K6 | 0.94918939 |
| 58 | PAK4 | 0.94844417 |
| 59 | MAP3K7 | 0.93722115 |
| 60 | CSNK1G2 | 0.92926976 |
| 61 | FGR | 0.92453752 |
| 62 | PIM2 | 0.91128951 |
| 63 | DYRK1B | 0.90460654 |
| 64 | PDGFRA | 0.90051911 |
| 65 | MAPK12 | 0.88062004 |
| 66 | YES1 | 0.87112872 |
| 67 | CDK4 | 0.86843942 |
| 68 | CSK | 0.86310093 |
| 69 | DYRK2 | 0.84859013 |
| 70 | MAP3K9 | 0.83043792 |
| 71 | WNK3 | 0.80254517 |
| 72 | NTRK3 | 0.78714769 |
| 73 | OXSR1 | 0.78187009 |
| 74 | LATS2 | 0.76802005 |
| 75 | CHEK2 | 0.76414964 |
| 76 | TAOK2 | 0.76184190 |
| 77 | PKN1 | 0.75396754 |
| 78 | CSNK1D | 0.74018246 |
| 79 | MAPK13 | 0.72137514 |
| 80 | STK16 | 0.71520366 |
| 81 | TXK | 0.71428966 |
| 82 | MAP3K10 | 0.71163499 |
| 83 | CCNB1 | 0.69952025 |
| 84 | IRAK4 | 0.69438416 |
| 85 | ALK | 0.68652739 |
| 86 | CDK6 | 0.67678524 |
| 87 | TAOK3 | 0.66079276 |
| 88 | RIPK1 | 0.63271722 |
| 89 | AKT2 | 0.61058604 |
| 90 | NTRK2 | 0.60918537 |
| 91 | MAP3K3 | 0.60286853 |
| 92 | CSNK1G1 | 0.59576965 |
| 93 | PDPK1 | 0.58532056 |
| 94 | MAP2K3 | 0.58308454 |
| 95 | SIK2 | 0.57133697 |
| 96 | PLK1 | 0.55992662 |
| 97 | SGK494 | 0.55828167 |
| 98 | SGK223 | 0.55828167 |
| 99 | SIK1 | 0.53726186 |
| 100 | ERBB2 | 0.53183906 |
| 101 | PDK2 | 0.52137052 |
| 102 | ITK | 0.50301924 |
| 103 | PRPF4B | 0.50029733 |
| 104 | CASK | 0.49870968 |
| 105 | IGF1R | 0.49584476 |
| 106 | RPS6KA6 | 0.48705913 |
| 107 | LYN | 0.47196412 |
| 108 | FLT3 | 0.46869606 |
| 109 | RPS6KA2 | 0.46798693 |
| 110 | STK39 | 0.45089162 |
| 111 | DDR2 | 0.43643257 |
| 112 | TRIM28 | 0.43614077 |
| 113 | CHEK1 | 0.43477238 |
| 114 | CDC42BPA | 0.42923581 |
| 115 | ATR | 0.42899367 |
| 116 | PRKCG | 0.42709126 |
| 117 | MAP3K4 | 0.41232355 |
| 118 | MAPK11 | 0.40423555 |
| 119 | EPHA4 | 0.37825628 |
| 120 | PRKD1 | 0.36813812 |
| 121 | PTK2 | 0.36500249 |
| 122 | MAPK10 | 0.36437438 |
| 123 | RPS6KL1 | 0.35929721 |
| 124 | RPS6KC1 | 0.35929721 |
| 125 | EIF2AK2 | 0.35728776 |
| 126 | STK38 | 0.33630692 |
| 127 | MARK1 | 0.33591001 |
| 128 | RPS6KA4 | 0.33574400 |
| 129 | PIM1 | 0.33507795 |
| 130 | BMPR1B | 0.33161317 |
| 131 | MTOR | 0.32472860 |
| 132 | BMX | 0.31688045 |
| 133 | EPHA3 | 0.29936465 |
| 134 | LATS1 | 0.29777648 |
| 135 | PRKD2 | 0.29000567 |
| 136 | PRKCD | 0.28975666 |
| 137 | IRAK1 | 0.28479820 |
| 138 | PAK6 | 0.28049593 |
| 139 | CDK2 | 0.27391250 |
| 140 | DYRK1A | 0.27322549 |
| 141 | INSR | 0.26083064 |
| 142 | GSK3A | 0.26063096 |
| 143 | PRKACG | 0.26042318 |
| 144 | MAPK4 | 0.25637150 |
| 145 | CSNK1E | 0.24582977 |
| 146 | PRKCI | 0.23927846 |
| 147 | SCYL2 | 0.23803398 |
| 148 | PAK3 | 0.22227831 |
| 149 | PRKACB | 0.22160789 |
| 150 | DAPK2 | 0.21621832 |
| 151 | PRKACA | 0.20801271 |
| 152 | GSK3B | 0.20743201 |
| 153 | RPS6KA3 | 0.20076671 |
| 154 | CDK15 | 0.19799933 |
| 155 | CDK18 | 0.18239362 |
| 156 | PRKCH | 0.16499291 |
| 157 | CDK11A | 0.15349308 |
| 158 | MAPK1 | 0.14711321 |
| 159 | PRKAA1 | 0.13896127 |
| 160 | SRC | 0.13848398 |
| 161 | PAK1 | 0.13225815 |
| 162 | PHKG1 | 0.12828368 |
| 163 | PHKG2 | 0.12828368 |
| 164 | CAMK1 | 0.12440180 |
| 165 | MAPK14 | 0.12342856 |
| 166 | CDK1 | 0.12253674 |
| 167 | MAPK8 | 0.12243746 |
| 168 | SIK3 | 0.12226659 |
| 169 | CDK14 | 0.11192079 |
| 170 | AURKA | 0.11068676 |
| 171 | CDK5 | 0.10923623 |
| 172 | MAP2K7 | 0.10038645 |
| 173 | ATM | 0.10023558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 6.66656072 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 6.30271077 |
| 3 | Sulfur relay system_Homo sapiens_hsa04122 | 4.83679199 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.77937261 |
| 5 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.32057230 |
| 6 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.99630476 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.75837352 |
| 8 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.52045923 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.46879656 |
| 10 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.40167577 |
| 11 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.38693617 |
| 12 | Galactose metabolism_Homo sapiens_hsa00052 | 2.30356976 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.19744123 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 2.09127370 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.00525227 |
| 16 | Thyroid cancer_Homo sapiens_hsa05216 | 1.90311291 |
| 17 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.86880875 |
| 18 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.70537506 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.69504563 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.69153421 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.67120494 |
| 22 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.65927892 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.57172126 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.52187878 |
| 25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.50970483 |
| 26 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.49143376 |
| 27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.49049680 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.46873613 |
| 29 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.43826232 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.43698453 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.39704119 |
| 32 | Prion diseases_Homo sapiens_hsa05020 | 1.39115721 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.38611320 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37286729 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.36275797 |
| 36 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.36264318 |
| 37 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.34512979 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.34247793 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.32784179 |
| 40 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.19375013 |
| 41 | GABAergic synapse_Homo sapiens_hsa04727 | 1.19366955 |
| 42 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.17030640 |
| 43 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.16832200 |
| 44 | Taste transduction_Homo sapiens_hsa04742 | 1.16800080 |
| 45 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.16472570 |
| 46 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.15522346 |
| 47 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.10056116 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09971988 |
| 49 | Malaria_Homo sapiens_hsa05144 | 1.09603195 |
| 50 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.09506388 |
| 51 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.09222505 |
| 52 | Leishmaniasis_Homo sapiens_hsa05140 | 1.07267241 |
| 53 | Morphine addiction_Homo sapiens_hsa05032 | 1.06363185 |
| 54 | Long-term depression_Homo sapiens_hsa04730 | 1.06155773 |
| 55 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.05051813 |
| 56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04518007 |
| 57 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.03820497 |
| 58 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.01738287 |
| 59 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.97096069 |
| 60 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.97079181 |
| 61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96419459 |
| 62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.94245538 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94216095 |
| 64 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.94173028 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.93305243 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91754765 |
| 67 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.90870916 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87565480 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87514780 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.85364036 |
| 71 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83935839 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83867723 |
| 73 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82544337 |
| 74 | Pathways in cancer_Homo sapiens_hsa05200 | 0.81959794 |
| 75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.81344534 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80768283 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79319357 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.78581281 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78512442 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78207007 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.78013400 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77502413 |
| 83 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.76401814 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75987843 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75188530 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.73899913 |
| 87 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.73711062 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.73355472 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.73336799 |
| 90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72820182 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.72479484 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72364428 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71683520 |
| 94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.70899592 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70581571 |
| 96 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70377132 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69841755 |
| 98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.69425848 |
| 99 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67608442 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64087532 |
| 101 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.63562701 |
| 102 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.63444976 |
| 103 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.61749011 |
| 104 | Cocaine addiction_Homo sapiens_hsa05030 | 0.60009181 |
| 105 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59481696 |
| 106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59254634 |
| 107 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58815746 |
| 108 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58584226 |
| 109 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.58312737 |
| 110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58180383 |
| 111 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.57335317 |
| 112 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55182938 |
| 113 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.54823100 |
| 114 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53975202 |
| 115 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.53787880 |
| 116 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53414243 |
| 117 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.53144072 |
| 118 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52958582 |
| 119 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51857795 |
| 120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51214124 |
| 121 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.50695214 |
| 122 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50430964 |
| 123 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.49929089 |
| 124 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48692979 |
| 125 | Tight junction_Homo sapiens_hsa04530 | 0.48215416 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45431078 |
| 127 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45302598 |
| 128 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45274322 |
| 129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44665254 |
| 130 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44653940 |
| 131 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44352012 |
| 132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44204865 |
| 133 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42835948 |
| 134 | Salivary secretion_Homo sapiens_hsa04970 | 0.42044549 |
| 135 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41466304 |
| 136 | Renin secretion_Homo sapiens_hsa04924 | 0.41113239 |
| 137 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40803789 |
| 138 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39908057 |
| 139 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39766479 |
| 140 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39509570 |
| 141 | Axon guidance_Homo sapiens_hsa04360 | 0.39424127 |
| 142 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.38889769 |
| 143 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.38843628 |
| 144 | Bile secretion_Homo sapiens_hsa04976 | 0.38765142 |
| 145 | Hepatitis C_Homo sapiens_hsa05160 | 0.38313344 |
| 146 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.37933119 |
| 147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37113837 |
| 148 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.36818404 |
| 149 | Measles_Homo sapiens_hsa05162 | 0.36060478 |
| 150 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35426690 |
| 151 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.34407730 |
| 152 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34125738 |
| 153 | Colorectal cancer_Homo sapiens_hsa05210 | 0.33794404 |
| 154 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.32030912 |
| 155 | Glioma_Homo sapiens_hsa05214 | 0.31139496 |
| 156 | Gap junction_Homo sapiens_hsa04540 | 0.29937881 |
| 157 | Circadian entrainment_Homo sapiens_hsa04713 | 0.29898749 |
| 158 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.28841126 |
| 159 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28624399 |
| 160 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.28188508 |
| 161 | Asthma_Homo sapiens_hsa05310 | 0.27955945 |
| 162 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.27942818 |
| 163 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.27878866 |
| 164 | Focal adhesion_Homo sapiens_hsa04510 | 0.27218056 |
| 165 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.26942692 |
| 166 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.26769358 |
| 167 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.26423290 |
| 168 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24761811 |
| 169 | Hepatitis B_Homo sapiens_hsa05161 | 0.24665350 |
| 170 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.23114831 |
| 171 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21999440 |
| 172 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.21560179 |
| 173 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21106722 |
| 174 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.20718224 |
| 175 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.18227849 |
| 176 | Insulin resistance_Homo sapiens_hsa04931 | 0.18082803 |
| 177 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17487447 |

